MedTrace Logo

Neuromuscular Versus Resistance Training on Functional Capacity in Patients With Heart Failure.

NCT07519473 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-04-09

No results posted yet for this study

Summary

This randomized controlled trial will compare the effects of neuromuscular training and resistance training on functional capacity, cardiorespiratory fitness, and lower limb performance in patients with chronic heart failure. A total of 40 participants will be randomly assigned into two groups in a single-blinded design.

Both groups will undergo a 10-week supervised exercise program. Outcomes will be assessed using VO₂ peak, 6-Minute Walk Test (6MWT), Short Physical Performance Battery (SPPB), and quality of life measures.

The study aims to determine the more effective rehabilitation approach for improving clinical outcomes in heart failure patients.

Conditions

Interventions

BEHAVIORAL

Resistance Training

A supervised resistance training program targeting major muscle groups using resistance bands, machines, and bodyweight exercises. Training intensity will be set at 50-70% of one-repetition maximum and progressed based on patient tolerance. Each session will include warm-up, 20 minutes of resistance exercises, 20 minutes of moderate-intensity aerobic exercise, and cool-down. Sessions will be conducted twice weekly for 10 weeks.

BEHAVIORAL

Neuromuscular Training

A supervised neuromuscular training program focusing on balance, coordination, proprioception, and postural control. Exercises will include dynamic balance tasks, limb coordination, and training on unstable surfaces. Each session will include warm-up, 20 minutes of neuromuscular exercises, 20 minutes of moderate-intensity aerobic exercise, and cool-down. Sessions will be conducted twice weekly for 10 weeks.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Arjumand Bano, MSPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2026-07-28
Completion
2026-07-29

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07519473 on ClinicalTrials.gov